CBM looks to boost viral vector manufacturing capabilities in cell line deal 19-Jan-2023 By Jane Byrne The unprecedented rise in approvals for new cell and gene therapies, and the increasing industry need for cell lines to support the production of therapeutics, has spurred US CDMO, the Center for Breakthrough Medicines (CBM), to act